Hao Chen

Closest collaborators

The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Taiping Zhang · 4 shared papers, 2019–2026 · strength 0.69
   • Paper Regulatory role of RNA modifications in the treatment of pancreatic ductal adenocarcinoma (PDAC). DOI 10.1016/j.heliyon.2023.e20969↗
   • Paper Nab-paclitaxel plus S-1 induction chemotherapy for patients with locally advanced pancreatic cancer: a multicenter, ope… DOI 10.1038/s41392-026-02741-1↗
   • Paper Mechanistic target of rapamycin in the tumor microenvironment and its potential as a therapeutic target for pancreatic … DOI 10.1016/j.canlet.2020.05.003↗
2. Wenhao Luo · 3 shared papers, 2020–2026 · strength 0.62
   • Paper Regulatory role of RNA modifications in the treatment of pancreatic ductal adenocarcinoma (PDAC). DOI 10.1016/j.heliyon.2023.e20969↗
   • Paper Nab-paclitaxel plus S-1 induction chemotherapy for patients with locally advanced pancreatic cancer: a multicenter, ope… DOI 10.1038/s41392-026-02741-1↗
   • Paper Mechanistic target of rapamycin in the tumor microenvironment and its potential as a therapeutic target for pancreatic … DOI 10.1016/j.canlet.2020.05.003↗
3. Yupei Zhao · 3 shared papers, 2019–2026 · strength 0.44
   • Paper Nab-paclitaxel plus S-1 induction chemotherapy for patients with locally advanced pancreatic cancer: a multicenter, ope… DOI 10.1038/s41392-026-02741-1↗
   • Paper Interleukin-17 activates and synergizes with the notch signaling pathway in the progression of pancreatic ductal adenoc… DOI 10.1016/j.canlet.2021.03.003↗
   • Paper Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinom… DOI 10.1038/s41422-019-0195-y↗
4. Zhe Cao · 2 shared papers, 2020–2026 · strength 0.36
   • Paper Nab-paclitaxel plus S-1 induction chemotherapy for patients with locally advanced pancreatic cancer: a multicenter, ope… DOI 10.1038/s41392-026-02741-1↗
   • Paper Mechanistic target of rapamycin in the tumor microenvironment and its potential as a therapeutic target for pancreatic … DOI 10.1016/j.canlet.2020.05.003↗
5. Jiangdong Qiu · 1 shared paper, 2026 · strength 0.26
   • Paper Nab-paclitaxel plus S-1 induction chemotherapy for patients with locally advanced pancreatic cancer: a multicenter, ope… DOI 10.1038/s41392-026-02741-1↗
6. Yuejuan Cheng · 1 shared paper, 2026 · strength 0.26
   • Paper Nab-paclitaxel plus S-1 induction chemotherapy for patients with locally advanced pancreatic cancer: a multicenter, ope… DOI 10.1038/s41392-026-02741-1↗
7. Chunmei Bai · 1 shared paper, 2026 · strength 0.26
   • Paper Nab-paclitaxel plus S-1 induction chemotherapy for patients with locally advanced pancreatic cancer: a multicenter, ope… DOI 10.1038/s41392-026-02741-1↗
8. Wenze Wang · 2 shared papers, 2019–2021 · strength 0.18
   • Paper Interleukin-17 activates and synergizes with the notch signaling pathway in the progression of pancreatic ductal adenoc… DOI 10.1016/j.canlet.2021.03.003↗
   • Paper Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinom… DOI 10.1038/s41422-019-0195-y↗
9. Junya Peng · 2 shared papers, 2019–2021 · strength 0.18
   • Paper Interleukin-17 activates and synergizes with the notch signaling pathway in the progression of pancreatic ductal adenoc… DOI 10.1016/j.canlet.2021.03.003↗
   • Paper Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinom… DOI 10.1038/s41422-019-0195-y↗
10. Wenming Wu · 2 shared papers, 2019–2021 · strength 0.18
    • Paper Interleukin-17 activates and synergizes with the notch signaling pathway in the progression of pancreatic ductal adenoc… DOI 10.1016/j.canlet.2021.03.003↗
    • Paper Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinom… DOI 10.1038/s41422-019-0195-y↗
11. Hongmei Dai · 1 shared paper, 2021 · strength 0.11
    • Paper Interleukin-17 activates and synergizes with the notch signaling pathway in the progression of pancreatic ductal adenoc… DOI 10.1016/j.canlet.2021.03.003↗
12. Xianze Wang · 1 shared paper, 2021 · strength 0.11
    • Paper Interleukin-17 activates and synergizes with the notch signaling pathway in the progression of pancreatic ductal adenoc… DOI 10.1016/j.canlet.2021.03.003↗
13. Junliang Lu · 1 shared paper, 2021 · strength 0.11
    • Paper Interleukin-17 activates and synergizes with the notch signaling pathway in the progression of pancreatic ductal adenoc… DOI 10.1016/j.canlet.2021.03.003↗
14. Mengyu Feng · 1 shared paper, 2020 · strength 0.10
    • Paper Mechanistic target of rapamycin in the tumor microenvironment and its potential as a therapeutic target for pancreatic … DOI 10.1016/j.canlet.2020.05.003↗
15. Jianchun Xiao · 1 shared paper, 2020 · strength 0.10
    • Paper Mechanistic target of rapamycin in the tumor microenvironment and its potential as a therapeutic target for pancreatic … DOI 10.1016/j.canlet.2020.05.003↗
16. Yueze Liu · 1 shared paper, 2020 · strength 0.10
    • Paper Mechanistic target of rapamycin in the tumor microenvironment and its potential as a therapeutic target for pancreatic … DOI 10.1016/j.canlet.2020.05.003↗
17. Gang Yang · 1 shared paper, 2020 · strength 0.10
    • Paper Mechanistic target of rapamycin in the tumor microenvironment and its potential as a therapeutic target for pancreatic … DOI 10.1016/j.canlet.2020.05.003↗
18. Fangyu Zhao · 1 shared paper, 2020 · strength 0.10
    • Paper Mechanistic target of rapamycin in the tumor microenvironment and its potential as a therapeutic target for pancreatic … DOI 10.1016/j.canlet.2020.05.003↗
19. Jiangdong Qiu · 1 shared paper, 2020 · strength 0.10
    • Paper Mechanistic target of rapamycin in the tumor microenvironment and its potential as a therapeutic target for pancreatic … DOI 10.1016/j.canlet.2020.05.003↗
20. Lei You · 1 shared paper, 2020 · strength 0.10
    • Paper Mechanistic target of rapamycin in the tumor microenvironment and its potential as a therapeutic target for pancreatic … DOI 10.1016/j.canlet.2020.05.003↗
21. Yusheng Chen · 1 shared paper, 2019 · strength 0.07
    • Paper Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinom… DOI 10.1038/s41422-019-0195-y↗
22. Quan Liao · 1 shared paper, 2019 · strength 0.07
    • Paper Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinom… DOI 10.1038/s41422-019-0195-y↗
23. Yi Liu · 1 shared paper, 2019 · strength 0.07
    • Paper Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinom… DOI 10.1038/s41422-019-0195-y↗
24. Menghua Dai · 1 shared paper, 2019 · strength 0.07
    • Paper Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinom… DOI 10.1038/s41422-019-0195-y↗
25. Junchao Guo · 1 shared paper, 2019 · strength 0.07
    • Paper Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinom… DOI 10.1038/s41422-019-0195-y↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.